Superoxide dismutase 3 protects mesenchymal stem cells through enhanced autophagy and regulation of FoxO3a trafficking

Therapeutic applications of mesenchymal stem cells (MSCs) are limited due to their early death within the first few days of transplantation. Therefore, to improve the efficacy of cell-based therapies, it is necessary to manipulate MSCs so that they can resist various stresses imposed by the microenv...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrahari, Gaurav, Sah, Shyam Kishor, Kim, Tae-Yoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089869/
https://www.ncbi.nlm.nih.gov/pubmed/29921412
http://dx.doi.org/10.5483/BMBRep.2018.51.7.078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089869/
https://www.ncbi.nlm.nih.gov/pubmed/29921412
http://dx.doi.org/10.5483/BMBRep.2018.51.7.078

Ejemplares similares